News Headline Summary

Securities fraud suits backed by US high court in Amgen (AMGN) case

Reaction details:

- Co. shares are unmoved in immediate reaction to the news; trades USD 89.71 last.

Print 15:05, 27 Feb 2013 - US Equities - Source: Newswires